Follow

Curasight A/S

Spotlight Stock Market (Sweden)

Curasight specializes in research and development of various drug candidates. The product portfolio includes research and development within Positron Emission Tomography (PET) and related ancillary services. The business is operating with the largest presence within Scandinavia.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
CURAS
DK0061295797
Spotlight Stock Market
Sweden (SE)
Details of share in Curasight A/S with ticker CURAS
Status
Active
Currency
DKK
First trading date
08 Oct 2020
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
CURAS
DK0061295797
Spotlight Stock Market
Sweden (SE)
Details of share in Curasight A/S with ticker CURAS
Status
Active
Currency
DKK
First trading date
08 Oct 2020
Type
Ticker
ISIN
Market
OPTION
CURAS TO1
DK0061408747
Spotlight Stock Market
Sweden (SE)
Details of option in Curasight A/S with ticker CURAS TO1
Status
Archived
Currency
DKK
Trading period
08 Oct 2020 - 05 Oct 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for DKK 17.20 during the subscription period September 16, 2021 - October 07, 2021.
Update (27.09.2021): Last trading day for warrants TO1 is October 5, 2021.
Exercise
Sign in to buy
People
Ulrich Krasilnikoff
CEO
Per Falholt
Chairman of the board
Andreas Kjær
Board member
Charlotte Vedel
Board member
Kirsten Drejer
Board member
Lars Trolle
Board member
Ulrich Krasilnikoff
Board member
Company Details
Sector
HEALTH CARE

Address
Ole Maaløes Vej 3
Zip code
2200
City/district
Copenhagen
Country
Denmark (DK)
Registration number
35249389
LEI code
984500C9E3ADR98F1070
First trade date
08 Oct 2020
Registration date
22 May 2013
Short name
CURAS

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More